Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
100
NCT06522711
Virtual Reality for Anxiolysis and Pharmacological Sparing
Phase: N/A
Role: Collaborator
Start: Sep 1, 2024
Completion: Sep 1, 2026